Patients Rising Now supports regulatory reforms that promote patient access, accelerate medical innovation and streamline the health care system. The proposed Philadelphia City Ordinance fails all three of these essential patient priorities. It potentially denies access to medical innovation and creates an undue burden on patients by potentially increasing out of pocket costs for treatments.
How can President Trump and Health and Human Services Secretary Alex Azar deliver on their new “American Patients First” plan to reduce prescription drug costs?
By focusing their evolving blueprint on the needs of patients, not lobbyists, who spend hundreds of millions of dollars each year to exert control over the many levers of health care policy. Patients are counting on reforms that don’t break what is working in an attempt to fix what’s not.
Patricia Bernard of Falmouth has unwittingly become the face of American seniors facing high drug costs.
Sen. Susan Collins recently invited Bernard to tell her story before the Senate Aging Committee, which Collins chairs. Diagnosed with rheumatoid arthritis 25 years ago, Bernard worked until age 79 to keep her employer-sponsored health insurance plan that allowed her to purchase the medication she needed for between $10 and $30 a month.